COVID-19 Vaccine Tweets After Vaccine Rollout: Sentiment-Based Topic Modeling

BackgroundCOVID-19 vaccines are one of the most effective preventive strategies for containing the pandemic. Having a better understanding of the public's conceptions of COVID-19 vaccines may aid in the effort to promptly and thoroughly vaccinate the community. However, because no empirical res...

Full description

Saved in:
Bibliographic Details
Main Authors: Luwen Huangfu (Author), Yiwen Mo (Author), Peijie Zhang (Author), Daniel Dajun Zeng (Author), Saike He (Author)
Format: Book
Published: JMIR Publications, 2022-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_95002471fb1d4d7e9768e5087f6b1acf
042 |a dc 
100 1 0 |a Luwen Huangfu  |e author 
700 1 0 |a Yiwen Mo  |e author 
700 1 0 |a Peijie Zhang  |e author 
700 1 0 |a Daniel Dajun Zeng  |e author 
700 1 0 |a Saike He  |e author 
245 0 0 |a COVID-19 Vaccine Tweets After Vaccine Rollout: Sentiment-Based Topic Modeling 
260 |b JMIR Publications,   |c 2022-02-01T00:00:00Z. 
500 |a 1438-8871 
500 |a 10.2196/31726 
520 |a BackgroundCOVID-19 vaccines are one of the most effective preventive strategies for containing the pandemic. Having a better understanding of the public's conceptions of COVID-19 vaccines may aid in the effort to promptly and thoroughly vaccinate the community. However, because no empirical research has yet fully explored the public's vaccine awareness through sentiment-based topic modeling, little is known about the evolution of public attitude since the rollout of COVID-19 vaccines. ObjectiveIn this study, we specifically focused on tweets about COVID-19 vaccines (Pfizer, Moderna, AstraZeneca, and Johnson & Johnson) after vaccines became publicly available. We aimed to explore the overall sentiments and topics of tweets about COVID-19 vaccines, as well as how such sentiments and main concerns evolved. MethodsWe collected 1,122,139 tweets related to COVID-19 vaccines from December 14, 2020, to April 30, 2021, using Twitter's application programming interface. We removed retweets and duplicate tweets to avoid data redundancy, which resulted in 857,128 tweets. We then applied sentiment-based topic modeling by using the compound score to determine sentiment polarity and the coherence score to determine the optimal topic number for different sentiment polarity categories. Finally, we calculated the topic distribution to illustrate the topic evolution of main concerns. ResultsOverall, 398,661 (46.51%) were positive, 204,084 (23.81%) were negative, 245,976 (28.70%) were neutral, 6899 (0.80%) were highly positive, and 1508 (0.18%) were highly negative sentiments. The main topics of positive and highly positive tweets were planning for getting vaccination (251,979/405,560, 62.13%), getting vaccination (76,029/405,560, 18.75%), and vaccine information and knowledge (21,127/405,560, 5.21%). The main concerns in negative and highly negative tweets were vaccine hesitancy (115,206/205,592, 56.04%), extreme side effects of the vaccines (19,690/205,592, 9.58%), and vaccine supply and rollout (17,154/205,592, 8.34%). During the study period, negative sentiment trends were stable, while positive sentiments could be easily influenced. Topic heatmap visualization demonstrated how main concerns changed during the current widespread vaccination campaign. ConclusionsTo the best of our knowledge, this is the first study to evaluate public COVID-19 vaccine awareness and awareness trends on social media with automated sentiment-based topic modeling after vaccine rollout. Our results can help policymakers and research communities track public attitudes toward COVID-19 vaccines and help them make decisions to promote the vaccination campaign. 
546 |a EN 
690 |a Computer applications to medicine. Medical informatics 
690 |a R858-859.7 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Journal of Medical Internet Research, Vol 24, Iss 2, p e31726 (2022) 
787 0 |n https://www.jmir.org/2022/2/e31726 
787 0 |n https://doaj.org/toc/1438-8871 
856 4 1 |u https://doaj.org/article/95002471fb1d4d7e9768e5087f6b1acf  |z Connect to this object online.